研究成果 (5)

排序依據：日期 | 題名

10 | 25 | 50 | 100

1/1

4 A B C D E F G H I L M N O P Q R S T U V W Z 全部

Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death
Lui VWY, Wong EYL, Ho K, Ng PKS, Lau CPY, Tsui SKW, Tsang CM, Tsao SW, Cheng SH, Ng MHL, Ng YK, Lam EKY, Hong B, Lo KW, Mok TSK, Chan ATC, Mills GB ( 2011 )
ONCOGENE
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1038/onc.2010.490
Initial Phase II Results with Crizotinib in Advanced ALK-Positive Non-Small-Cell Lung Cancer (NSCLC): PROFILE 1005
MOK Shu Kam Tony, CRINO L, KIM D, RIELY Gj, JANNE Pa, BLACKHALL Fh, CAMIDGE Dr, HIRSH V, SOLOMON Bj, PARK K, GADGEEL Sm, MARTINS R, HAN J, DE PAS Tm, BOTTOMLEY A, POLLI A, PETERSEN J, TASSELL Vr, SHAW At ( 2011 )
2011 ASCO Annual Meeting Proceedings
Invited conference paper presented and published in conference proceedings
INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer
Wu YL, Park K, Soo RA, Sun Y, Tyroller K, Wages D, Ely G, Yang JCH, Mok T ( 2011 )
BMC CANCER
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1186/1471-2407-11-430
Intercalated Erlotinib with Gemcitabine/Platinum in the First-Line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC): The Phase III, Placebo-controlled FASTACT-II Study
LEE Jin Soo, WU Yi-long, LADRERA Guia, SRIMUNINNIMIT Vichien, SRIURANPONG Virote, THONGPRASERT Sumitra, YU Chong-jen, ZHANG Li, MARGONO Benjamin, MOK Shu Kam Tony ( 2011 )
Proceedings of the 14th World Conference on Lung Cancer
Invited conference paper presented and published in conference proceedings
INTERCALATED ERLOTINIB WITH GEMCITABINE/PLATINUM IN THE FIRST-LINE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC): THE PHASE III, PLACEBO-CONTROLLED FASTACT-II STUDY
Lee JS, Wu YL, Ladrera G, Srimuninnimit V, Sriuranpong V, Thongprasert S, Yu CJ, Zhang L, Margono B, Mok T ( 2011 )
JOURNAL OF THORACIC ONCOLOGY
Other conference paper

10 | 25 | 50 | 100

1/1

研究成果 (5)

分享連結

Our policy towards the use of cookies